Consensus-led recommendations supporting choice and personalisation of hormone replacement therapy in menopause care
Open accessAbstract
OBJECTIVE: Inequity of access and choice to different hormone replacement therapy (HRT) products across the UK has been suggested (Hillman, 2020). While, the cause is not entirely understood, potential contributors include conflicting national guidance, economic deprivation and a local formulary approach. With a diverse and growing population of women reaching and living well beyond the menopause, the impact of this inequity is becoming more pronounced, and challenges the goal of providing personalised care. The study objective is to establish a consensus that supports a greater equity of access and choice of HRT and provision of individualised care. STUDY DESIGN: scale questionnaire, sent to UK HCPs, was used to assess agreement, with a consensus threshold set at 75%. MAIN OUTCOME MEASURES: 150 HCP responses between June and September 2021. RESULTS: A total of 137 responses were received. Analysis identified 37/40 statements attaining very high agreement (≥ 90%) and 3/40 statements attaining high agreement (< 90% and ≥75%). Nine recommendations were developed with the intent to inform potential improvements to menopause care in the UK. CONCLUSIONS: The high levels of agreement displayed suggest a desire to change the way menopause care is delivered in the UK. Implementation of the suggested recommendations has the potential to improve equity of access to licensed treatment options, compliant with the NICE recommendation for personalisation of care.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the UK, access and availability to all treatment options was recognized as an important factor for shared decision-making which can improve medication adherence.
“In the UK, it was recognized that access and availability to all treatment options was an important factor for shared decision-making which can improve medication adherence.313”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [313]
Cites
Premature menopause or early menopause: Long-term health consequences
Shuster, L. T., Rhodes, D. J., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.08.003 · Cited by 808 · see citing works
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 515 · see citing works
The Controversial History of Hormone Replacement Therapy
Cagnacci, A., & Venier, M. (2019) · Medicina · doi:10.3390/medicina55090602 · Cited by 300 · see citing works
Menopausal hormone therapy and women’s health: An umbrella review
Zhang, G.-Q., Chen, J.-L., Luo, Y., Mathur, M. B., Anagnostis, P. G., Nurmatov, U. B., Talibov, M., Zhang, J., Hawrylowicz, C. M., Lumsden, M. A., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003731 · Cited by 218 · see citing works
Hamoda, H., Panay, N., Pedder, H., Arya, R., & Savvas, M. (2020) · Post Reproductive Health · doi:10.1177/2053369120957514 · Cited by 192 · see citing works
Self-citationFiorillo, A., Barlati, S., Bellomo, A., Corrivetti, G., Nicolò, G., Sampogna, G., Stanga, V., Veltro, F., Maina, G., & Vita, A. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00293-4 · Cited by 110 · see citing works
Constantine, G. D., Graham, S., Clerinx, C., Bernick, B. A., Krassan, M., Mirkin, S., & Currie, H. D. (2016) · Post Reproductive Health · doi:10.1177/2053369116632439 · Cited by 87 · see citing works
Vinogradova, Y., Dening, T., Hippisley-Cox, J., Taylor, L., Moore, M., & Coupland, C. (2021) · British medical journal · doi:10.1136/bmj.n2182 · Cited by 83 · see citing works
Future of an Ageing Population
Beech, L. (2016) · Cited by 78 · see citing works
Decline in use of hormone therapy among postmenopausal women in the United Kingdom
Menon, U., Burnell, M., Sharma, A., Gentry‐Maharaj, A., Fraser, L. S. M., Ryan, A., Parmar, M., Hunter, M. S., & Jacobs, I. J. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000243569.70946.9d · Cited by 55 · see citing works
Socioeconomic status and HRT prescribing: a study of practice-level data in England
Hillman, S., Shantikumar, S., Ridha, A., Todkill, D., & Dale, J. R. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x713045 · Cited by 51 · see citing works
Angus, R., Thompson, E., Davies, L., Trusdale, A., Hodgson, C., McKnight, E., Davies, A., & Pearson, M. G. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00088 · Cited by 29 · see citing works
Best practice for HRT: unpicking the evidence
Newson, L. R. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x687097 · Cited by 16 · see citing works
Sex hormones and venous thromboembolism – from contraception to hormone replacement therapy
Beyer‐Westendorf, J., Bauersachs, R. M., Hach-Wunderle, V., Zotz, R. B., & Rott, H. (2018) · VASA · doi:10.1024/0301-1526/a000726 · Cited by 16 · see citing works
British Menopause Society vision for menopause care in the UK
Currie, H. D., Abernethy, K., Gray, S., & on behalf of the British Menopause Society Medical Advisory Council (2017) · Post Reproductive Health · doi:10.1177/2053369117717207 · Cited by 14 · see citing works
Menopause in the workplace: Building evidence, changing workplaces, supporting women
Jack, G. A., Riach, K., Hickey, M., Griffiths, A., Hardy, C., & Hunter, M. S. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.07.001 · Cited by 11 · see citing works
Chakrabarti, B., Lewis-Burke, N., Pearson, M. G., Craig, S., Davies, L., Sheridan, K., England, P., McKnight, E., & Angus, R. (2020) · ERJ Open Research · doi:10.1183/23120541.00362-2019 · Cited by 5 · see citing works
Premature ovarian insufficiency
Zaman, N., Williamson, J., & Robinson, L. L. L. (2016) · CRC Press eBooks · doi:10.1201/b19647-91 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224 · see citing works
The evolving perspective of menopause management in the United Kingdom
Mansour, D., Barber, K., Chalk, G., Noble, N., Digpal, A. A. S., Talaulikar, V. S., & Gray, S. (2024) · Women s Health · doi:10.1177/17455057241288641 · Cited by 16 · see citing works
Self-citationStute, P., Bińkowska, M., Briggs, P., Palacios, S., Abetz‐Webb, L., Law, V., Zablotna-Pociupany, R., & Boolell, M. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108195 · Cited by 2 · see citing works
Self-citation
- Authors
- Briggs, P., Barber, K., Cooke, K., Hillard, T., Mansour, D., Panay, N., Pearson, K., Tanna, N., & Wokoma, T.
- Affiliations
- Liverpool Women's Hospital (GB)
- General Practitioner with Extended Role in Menopause and Gynaecology, Woodlands Medical Centre, Oxford, UK
- Consultant Nurse, Gynaecology, Liverpool, UK
- Consultant Gynaecologist, University Hospitals Dorset, Poole, UK
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Consultant Gynaecologist, London, UK
- Head of Medicines Optimisation, NHS Heywood Middleton and Rochdale Clinical Commissioning Group, Manchester, UK
- Pharmacist Consultant, Womens Services, London, UK
- Consultant Community Sexual & Reproductive Health, City Healthcare Partnership, Hull, UK
- Corresponding author
- Briggs, Paula
- Venue
- Post Reproductive Health
- Publisher
- Informa UK Limited
- Published
- 2022-04-20
- Volume
- 28
- Issue
- 2
- Pages
- 71-78
- ISSN
- 2053-3370 (ISSN-L)
- 2053-3691
- 2053-3705
- OpenAlex
- W4224229984
- Cited by
- 3
- References
- 18
- Citations by year
- 2025: 1 · 2024: 2
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Post Reproductive Health (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Theramex HQ UK Ltd
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- hormone replacement therapy, menopause care, individualized care, equitable access, consensus recommendations, healthcare professionals' views, NICE guidelines, economic hardship
- MeSH terms
- Female, Humans, Menopause, Surveys and Questionnaires, Estrogen Replacement Therapy, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
